Donckier et al. recruited 5 patients with advanced hepatocellular carcinoma (HCC) who underwent living liver transplantation and received donor CD34+ stem cell transfusion based on the induction regimen of non-myeloablative therapy. This evidence concerns the gene CD34 and hepatocellular carcinoma.